Previous Article | Next Article ![]()
Infection and Immunity, September 1999, p. 4418-4426, Vol. 67, No. 9
Laboratory of Plasma Derivatives, Division of
Hematology, Center for Biologics Evaluation and Research, U.S. Food
and Drug Administration, Bethesda, Maryland 20852
Received 16 March 1999/Returned for modification 21 May
1999/Accepted 9 June 1999
Down-regulation of the Th2-like response induced by ovalbumin-alum
(OVA/alum) immunization by heat-killed Brucella abortus was
not reversed by anti-IL-12 antibody treatment or in gamma interferon
(IFN-
0019-9567/99/$04.00+0
Down-Regulation of Th2 Responses by Brucella
abortus, a Strong Th1 Stimulus, Correlates with Alterations in the
B7.2-CD28 Pathway
) knockout mice, suggesting that induction of Th1 cytokines was
not the only mechanism involved in the B. abortus-mediated inhibition of the Th2 response to OVA/alum. The focus of this study was
to determine whether an alternative pathway involves alteration in
expression of costimulatory molecules. First we show that the Th2-like
response to OVA/alum is dependent on B7.2 interaction with ligand since
it can be abrogated by anti-B7.2 treatment. Expression of costimulatory
molecules was then studied in mice immunized with OVA/alum in the
absence or presence of B. abortus. B7.2, but not B7.1, was
up-regulated on mouse non-T and T cells following immunization with
B. abortus. Surprisingly, B. abortus induced
down-regulation of CD28 and up-regulation of B7.2 on murine
CD4+ and CD8+ T cells. These effects on T cells
were maximal for CD28 and B7.2 at 40 to 48 h and were not
dependent on interleukin-12 (IL-12) or IFN-
. On the basis of these
results, we propose that the IL-12/IFN-
-independent inhibition of
Th2 responses to OVA/alum is secondary to the effects of B. abortus on expression of costimulatory molecules on T cells. We
suggest that down-regulation of CD28 following activation inhibits subsequent differentiation of Th0 into Th2 cells. In addition, decreased expression of CD28 and increased expression of B7.2 on T
cells would favor B7.2 interaction with CTLA-4 on T cells, and this
could provide a negative signal to developing Th2 cells.
*
Corresponding author. Mailing address: Bldg. 29, Rm.
232, 1401 Woodmont, Rockville Pike, Rockville, MD 20852. Phone: (301) 827-3017. Fax: (301) 402-2780. E-mail:
GOLDING{at}CBER.FDA.GOV.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»